Indian court order for free coronavirus testing may hinder fight, say business leaders, health experts via sanjeevmiglani DevjyotGhoshal
NEW DELHI - A decision by the Supreme Court of India to make testing for coronavirus free places an unfair financial burden on medical firms and could see a reduction in testing, already among the world’s lowest, said business leaders and health experts.
Kiran Mazumdar Shaw, executive chairperson of Biocon Limited, one of India’s biggest biotech firms, said private institutions could not be expected to operate on credit. The top court, responding to a public interest petition, said on Wednesday private medical institutions should be playing a philanthropic role at a time of national crisis and it would not allow a situation where India’s poor could not afford a test for the virus that is quickly spreading through the country.
The numbers are small compared to the United States, Italy and Spain and one of the reasons is that the country is testing a narrow range of the population, doctors say. The plan is to scale up to 20,000 tests in the next few days and eventually to 100,000 a day in the worse-case scenario. The health sector like others parts of the Indian economy is struggling and in no position to offer a free ride, she said.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Indian states scramble for funds as virus takes toll on coffersA three-week nationwide lockdown is testing the resilience of India's state governments, with analysts warning that essential public services and health care for millions of Indians will be in jeopardy without further federal and central bank support.
Read more »
What Africa and an Indian state tell us about containing past contagionsSome countries have succeeded in controlling outbreaks of deadly viruses in the not-so-distant past. And rigorous tracking of suspected carriers has been crucial
Read more »
Indian Health Service Expands Telehealth Services During COVID-19 ResponseToday, IHS is announcing its expansion of telehealth across IHS federal facilities. Telehealth services means patients can stay home and reduce their risk of infection and also keep healthcare workers and others in waiting rooms and emergency departments safe from COVID-19.
Read more »
U.S. Is Suddenly OK With Indian Hydroxychloroquine Maker It Banned For Multiple ViolationsThe US Food and Drug Administration has lifted a 3 year-long import ban on chloroquine products manufactured by Mumbai-based Ipca Laboratories, a company that it last investigated in August 2019.
Read more »
New coronavirus unemployment assistance guidance may leave out workers it is supposed to help, experts sayOne expert even called the rules 'criminally narrow' and argued that they will 'greatly undermine the effectiveness of the system.'
Read more »